Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer. [electronic resource]
Producer: 20181106Description: 312.e9-312.e15 p. digitalISSN:- 1873-2496
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- blood
- Bone Neoplasms -- blood
- Case-Control Studies
- Drug Resistance, Neoplasm
- Follow-Up Studies
- Humans
- Lymphatic Metastasis
- Male
- Middle Aged
- Neoplasm Invasiveness
- Prognosis
- Prospective Studies
- Prostatic Neoplasms, Castration-Resistant -- blood
- Survival Rate
- Syndecan-1 -- blood
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.